The Supreme Court justices on Tuesday heard a case involving whetherfederal law governing the Food and Drug Administration’s pre-marketapproval of medical devices pre-empts state product liability claims. Asecond argument concerned peremptory challenges to African-Americanjurors in a death penalty case in which the prosecutor made referencesto the O.J. Simpson murder trial.
Riegel v. Medtronic asks whether state law product liabilityclaims involving medical devices that received pre-market approval bythe FDA are pre-empted by a provision of the Medical Device Amendmentsto the Food, Drug and Cosmetic Act.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
